Fmr LLC Amphastar Pharmaceuticals, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Fmr LLC holds 27,752 shares of AMPH stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,752

Previous 20,886 32.87%

Holding current value

$1.28 Million

Previous $917,000 21.05%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$38.65 - $43.48 $265,370 - $298,533	6,866 Added 32.87%	27,752 $1.11 Million
Q1 2024 May 13, 2024	BUY	$42.85 - $63.45 $63,460 - $93,969	1,481 Added 7.63%	20,886 $917,000
Q4 2023 Feb 13, 2024	SELL	$44.49 - $62.93 $329,982 - $466,751	-7,417 Reduced 27.65%	19,405 $1.2 Million
Q3 2023 Nov 13, 2023	SELL	$45.51 - $65.0 $154,460 - $220,610	-3,394 Reduced 11.23%	26,822 $1.23 Million
Q2 2023 Aug 11, 2023	BUY	$35.77 - $58.38 $2,181 - $3,561	61 Added 0.2%	30,216 $1.74 Million
Q1 2023 May 11, 2023	BUY	$27.99 - $37.92 $23,707 - $32,118	847 Added 2.89%	30,155 $1.13 Million
Q4 2022 Feb 13, 2023	BUY	$27.93 - $31.27 $893 - $1,000	32 Added 0.11%	29,308 $821,000
Q3 2022 Nov 10, 2022	SELL	$27.56 - $37.75 $6,366 - $8,720	-231 Reduced 0.78%	29,276 $823,000
Q2 2022 Aug 12, 2022	SELL	$29.79 - $42.29 $3,515 - $4,990	-118 Reduced 0.4%	29,507 $1.03 Million
Q1 2022 May 13, 2022	BUY	$22.96 - $36.45 $680,190 - $1.08 Million	29,625 New	29,625 $1.06 Million
Q3 2021 Nov 15, 2021	SELL	$17.83 - $21.49 $2,228 - $2,686	-125 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$17.11 - $20.92 $2,138 - $2,615	125 New	125 $2,000

Others Institutions Holding AMPH

# of Institutions

282

Shares Held

35.2M

Call Options Held

25.5K

Put Options Held

24.8K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $2.26B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account